239 related articles for article (PubMed ID: 7070726)
41. Visual inspection of the uterine cervix after the application of acetic acid in the detection of cervical carcinoma and its precursors.
Sankaranarayanan R; Wesley R; Somanathan T; Dhakad N; Shyamalakumary B; Amma NS; Parkin DM; Nair MK
Cancer; 1998 Nov; 83(10):2150-6. PubMed ID: 9827719
[TBL] [Abstract][Full Text] [Related]
42. [Studies of screening, detection and mortality rates in mass screening for uterine cervical cancer in Shimane prefecture].
Takahashi K; Moriyama M; Takamiya O; Shibukawa T; Iwanari O; Matsunaga I; Kitao M
Nihon Sanka Fujinka Gakkai Zasshi; 1985 Mar; 37(3):377-82. PubMed ID: 3981047
[TBL] [Abstract][Full Text] [Related]
43. Differences in screening history, tumour characteristics and survival between women with screen-detected versus not screen-detected cervical cancer in the east of The Netherlands, 1992-2001.
van der Aa MA; Schutter EM; Looijen-Salamon M; Martens JE; Siesling S
Eur J Obstet Gynecol Reprod Biol; 2008 Aug; 139(2):204-9. PubMed ID: 18093720
[TBL] [Abstract][Full Text] [Related]
44. [Increase of in-situ cervix uteri carcinoma in women under 35; data analysis from family practice 1974-1986].
Boon ME; Rietveld WJ; de Graaff Guilloud JC
Ned Tijdschr Geneeskd; 1988 Jul; 132(27):1240-3. PubMed ID: 2840584
[No Abstract] [Full Text] [Related]
45. Cytopathology and the management of early invasive cancer of the uterine cervix.
Johnston WW; Myers B; Creasman WT; Owens SM
Obstet Gynecol; 1982 Sep; 60(3):350-3. PubMed ID: 7121916
[TBL] [Abstract][Full Text] [Related]
46. Validity of combined cytology and human papillomavirus (HPV) genotyping with adjuvant DNA-cytometry in routine cervical screening: results from 31031 women from the Bonn-region in West Germany.
Bollmann R; Bankfalvi A; Griefingholt H; Trosic A; Speich N; Schmitt C; Bollmann M
Oncol Rep; 2005 May; 13(5):915-22. PubMed ID: 15809758
[TBL] [Abstract][Full Text] [Related]
47. [Possibilities of cytologic diagnosis of uterine cervix carcinoma in situ].
Novik VI
Vopr Onkol; 1996; 42(5):109-12. PubMed ID: 9064894
[TBL] [Abstract][Full Text] [Related]
48. [Study on the maintenance of the accuracy of cytological diagnosis in the mass screening of uterine cervical cancer].
Takahashi K; Yamane Y; Fukuda S; Kijima S; Moriyama M; Kitao M
Nihon Sanka Fujinka Gakkai Zasshi; 1986 May; 38(5):633-7. PubMed ID: 3722946
[TBL] [Abstract][Full Text] [Related]
49. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group.
Lynge E
APMIS Suppl; 1998; 83():1-44. PubMed ID: 9850674
[TBL] [Abstract][Full Text] [Related]
50. Urbanization and the incidence of abnormalities of squamous and glandular epithelium of the cervix.
Boon ME; van Ravenswaay Claasen HH; van Westering RP; Kok LP
Cancer; 2003 Feb; 99(1):4-8. PubMed ID: 12589639
[TBL] [Abstract][Full Text] [Related]
51. [Diagnosis and treatment of invasive cervical cancer in Cambodia (apropos of 35 cases)].
Monchy D; Lieng CR; Kruy LS; Kahler K; Eav S
Bull Soc Pathol Exot; 2005 Sep; 98(3):183-6. PubMed ID: 16267957
[TBL] [Abstract][Full Text] [Related]
52. Risk factors for cervical neoplasia in Denmark.
Kjaer SK
APMIS Suppl; 1998; 80():1-41. PubMed ID: 9693662
[TBL] [Abstract][Full Text] [Related]
53. Dysplasia, carcinoma in situ, and invasive carcinoma of the cervix uteri in previously screened women.
Hoeg K; Roger V
Scand J Clin Lab Invest Suppl; 1968; 106():173-80. PubMed ID: 5731703
[No Abstract] [Full Text] [Related]
54. [A retrospective study of carcinoma of the uterine cervix and the value of cytological cervix studies in healthy women].
Barentsz JO; Muizebelt F; van der Schee AC; Toonen-van Beek AA
Ned Tijdschr Geneeskd; 1979 Nov; 123(45):1932-6. PubMed ID: 514382
[No Abstract] [Full Text] [Related]
55. Recent negative cytology prior to histologically confirmed carcinoma in situ of the cervix.
Mitchell H; Higgins V
Aust N Z J Obstet Gynaecol; 1994 May; 34(2):178-81. PubMed ID: 7980308
[TBL] [Abstract][Full Text] [Related]
56. [Cytological and epidemiological aspects of cancer of the uterine cervix. Comparison of the in situ and the invasive types].
del Ponce M; Sariol H; Rodríguez N; Javech C; Vadés Vivó P
Ginecol Obstet Mex; 1976 Jun; 39(236):477-83. PubMed ID: 947830
[No Abstract] [Full Text] [Related]
57. Experience of a continuing mass screening programme. Screening and re-screening for cervical carcinoma in Turku.
Grönroos M; Tyrkkö J; Järvi O; Rauramo L
Ann Chir Gynaecol Fenn; 1974; 63(6):470-8. PubMed ID: 4441027
[No Abstract] [Full Text] [Related]
58. Changes of morbidity and mortality from cancer of the cervix uteri in Puerto Rico.
Martínez I
Bol Asoc Med P R; 1984 Mar; 76(3):100-6. PubMed ID: 6586182
[No Abstract] [Full Text] [Related]
59. Ten years of screening for cancer in a family practice.
Berner JS; Frame PS; Dickinson JC
J Fam Pract; 1987 Mar; 24(3):249-52. PubMed ID: 3819663
[TBL] [Abstract][Full Text] [Related]
60. Carcinoma in situ and invasive squamous cell carcinoma associated with schistosomiasis of the uterine cervix a report of three cases.
Coelho LH; Carvalho G; Carvalho JM
Acta Cytol; 1979; 23(1):45-8. PubMed ID: 285551
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
